Technology ID
TAB-2672
Human Influenza Virus Real-time RT-PCR Detection and Characterization Panel
E-Numbers
E-331-2013-0
Lead Inventor
Lindstrom, Stephen
Lead IC
CDC
Co-Inventors
Klimov, Alexander
Cox, Nancy
Loftin, Lamorris
ICs
CDC
Applications
Therapeutics
Research Materials
Occupational Safety and Health
Diagnostics
Consumer Products
Therapeutic Areas
Infectious Disease
Development Stages
Pre-Clinical (in vitro)
Development Status
In vitro data available
This invention relates to methods of rapidly detecting influenza, including differentiating between type and subtype. Unlike culture and serological tests requiring 5 to 14 days for completion, CDC researchers developed a rapid, accurate assay, which is easily adapted to kit form. This assay also requires less labor input than immunoassays. These methods can be used to quickly identify a broad variety of influenza types and subtypes, including viruses that may be involved in pandemics (such as H5N1, for example).
Commercial Applications
- Influenza diagnostic using clinical specimens
- High-throughput screenings
- Influenza surveillance programs
Competitive Advantages
- Already FDA approved
- Especially useful for H5N1 screening
- Sensitive detection
- Specific discrimination of influenza subtypes
- Easily formatted as kit or array
- Faster than culturing and serological identification methods
- Less laborious and more objective than immunoassays
Licensing Contact: